addition to mCAR1 and mCAR2, there was one additional clone containing 188 bp of unspecified intron-derived sequence. However, it is unclear whether this clone corresponds to an authentic variant or a contaminating nuclear precursor. None of the human and murine CAR SVs identified to date transactivate CAR response element (CRE)-driven reporter genes either alone or in the presence of activators except for the hCAR SV with a 12-bp (4 amino acids) insertion from intron 6 which showed marginal activity. 5, 7) In order to elucidate the mechanisms of organ specificity involved in the phenobarbital (PB)-dependent induction of rat CYP2B forms under the control of promoters consisting of phenobarbital-responsive enhancer module (PBREM), the CAR transcripts in both liver and lung were sequenced. Wild-type CAR (CAR WT) mRNA was detected only in liver. Two CAR SVs (CAR SV4 and SV5) transcribed from the rat CAR (rCAR) gene were simultaneously detected in liver, while CAR SV5 was solely detected in lung (deposited with accession numbers AB104736 and AB105072, respectively). 9) It has been estimated that many mammalian genes generate divergent RNA transcripts by alternative promoter usage and/or exon splicing. As for human, mouse and rat CARs, only the latter has been reported. An extensive search for rCAR isoforms resulted in the novel discovery of three more CAR SVs (CAR SV1, SV2 and SV3). In this paper, so far detected CAR SVs and novel SVs in the rat liver and lung were studied for their structural and functional properties in comparison with those of CAR WT.
MATERIALS AND METHODS

Animals and Treatment
Seven-week-old male Wistar rats (Clea Japan, Tokyo, Japan) were kept under a 12-h lightdark cycle and provided food and water ad libitum. The livers and lungs were used for the isolation of total RNA. Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen Corp., Carlsbad, CA, U.S.A.) containing 10% fetal bovine serum and penicillin-streptomycin in a humidified atmosphere containing 5% CO 2 at 37°C.
Cell Culture Conditions HepG2 cells were cultured in
RT-PCR and Amplification of Hepatic and Pulmonary CAR cDNAs Total RNA was extracted from each homogenate of rat liver and lung using the RNeasy Midi Kit (Qiagen, Hilden, Germany). After incubation at 65°C for 10 min, the total RNA extract was quickly placed in an icecold water bath. The total RNA extract thus obtained and oligo-dT primer were added to RTG You-Prime First-Strand Beads (Amersham Biosciences, NJ, U.S.A.), and after 1 min at room temperature the reverse transcription proceeded at 37°C for 1 h to obtain cDNA, to which a primer pair, Pyrobest DNA polymerase (TAKARA, Japan), 10ϫPyrobest Buffer II and a dNTP Mixture were added. After the total volume was adjusted to 25 ml, the cDNA was amplified for 30 cycles of denaturation at 98°C for 10 s, annealing at 58°C for 30 s and extension at 72°C for 1.5 min in a thermal cycler. The following oligonucleotides were used as sense and antisense primers, respectively: 5Ј-CGC GGA TCC ATG ACA GCT ACT CTA A-3Ј and 5Ј-ATC CTC GAG TCA GCT GCA AAT CTC C-3Ј, where shaded boxes represent BamH I and XhoI sites, respectively.
The reaction products were separated by agarose gel electrophoresis and analyzed using a Fluor Imager (Amersham Biosciences) after staining with ethidium bromide.
Subcloning and Sequencing of PCR Products The PCR-amplified hepatic and pulmonary CAR cDNAs were ligated to Zero Blunt TOPO Vectors (Invitrogen Corp.). Plasmid DNA was transformed into competent E. coli cells (XL-1 Blue), and plasmids harboring the RT-PCR products were purified using the Quantum Prep ® Plasmid Miniprep Kit (Bio-Rad Laboratories, Hercules, CA, U.S.A.). The nucleotide sequencing of resulting plasmids was carried out using a Thermo Sequenase Cy5.5 Dye Terminator Cycle Sequencing Kit and GeneRapid (Amersham Biosciences, Model Seq4x4). The Zero Blunt TOPO Vector-specific sequence primers are as follows with the annealing temperatures in parentheses: T3 primer (58°C), 5Ј-ATT AAC CCT CAC TAA AGG GA-3Ј; T7 primer (54°C), 5Ј-TAA TAC GAC TCA CTA TAG GG-3Ј.
Western Blot Analysis Liver and lung homogenates were centrifuged at 600ϫg for 10 min to precipitate the nuclear fraction. The supernatant was further centrifuged at 10500ϫg for 60 min to precipitate the microsomal fraction. The supernatant was the cytosolic fraction. The protein concentration of the cytosolic fraction was quantitated using a 2-D Quant Kit (Amersham Biosciences). One hundred micrograms of cytosolic proteins and 25 mg of nuclear proteins were separated on a 10% SDS-polyacrylamide gel and transferred to a PVDF membrane. The membrane was treated with goat anti-rat CAR (Santa Cruz, U.S.A.) and peroxidaselabeled anti-goat IgG. Chemiluminescence was determined using the Western blotting detection reagent, ECL-Plus (Amersham Biosciences). The protein band-images were read with a Storm TM 830 (Amersham Biosciences) and analyzed with Image Quant software.
Rat CAR Expression Plasmids and the Reporter Plasmid The CAR SVs were digested from TOPO vector by BamH I and XhoI, and cloned into pcDNA 3.1 (Invitrogen Corp.).
The PBREM-pGL3 reporter plasmid was constructed by ligating the PBREM sequence into the SacI and BglII sites of the pGL3-Promoter Vector (Promega, U.S.A.). A double stranded PBREM nucleotide sequence was prepared by annealing the following synthetic oligomers: 5Ј-GAA TTC TCT GTA CTT TCC TGA CCT TGG CAC AGT GCC ACC A TC AAC TTG ACT GAC ACC A-3Ј and GAT CTG GTG TCA GTC AAG TTG ATG GTG GCA CTG TGC CAA GGT CAG GAA AGT ACA GAG AAT TCA GCT-3Ј.
Site-Directed Mutagenesis of CAR SV4 Site-directed mutagenesis was performed on the pcDNA-CAR SV4 expression plasmid using a QuickChange Site-directed Mutagenesis Kit (Stratagene, CA, U.S.A.). The forward version of the mutagenic primer and reverse primer are 5Ј ATG GCT CTC TTC TCT CCT GGA GAG AAC CAT-3Ј (the altered nucleotide, which introduces a silent mutation, is underlined) and 5Ј-CCA GGA GAG AAG AGA GCC ATG GCA GCC-3Ј, respectively. The sequence of the mutant CAR SV4 DNA was confirmed by sequencing.
Expression Profiles of pcDNA-CAR WT, SVs and SV4mut Plasmids in Transfected HepG2 Cells HepG2 cells were subcultured on 6-well plates for 24 h and transfected with 500 ng of individual pcDNA-CAR expression plasmids with the help of a mixture of TransFast (Promega) and OPTI-MEM (Invitrogen Corp.) for 2 h until DMEM was added to the culture. After 24 h, total RNA was extracted from transfected cells using a SV Total RNA Isolation System (Promega). After reverse-transcription, cDNA was amplified using Blend Taq DNA Polymerase (TOYOBO, Japan) and CAR-specific primers, including exon 5 through 9.
Transient Transfection and Reporter Gene Assay HepG2 cells were subcultured on 48-well plates. Twenty-four hours later, the cells were transfected in each well with 100 ng of PBREM-pGL3 reporter plasmid, 25 ng of phRL-SV40 control plasmid (Promega) and pcDNA-CAR WT and/or individual SV expression plasmids according to the same procedures. The total DNA content was adjusted to 325 ng with pcDNA empty plasmid. After overnight incubation, the reporter assay was performed using the Dual-Luciferase Reporter Assay System (Promega) and a Turner Designs Luminometer (Model TD-20/20, Promega).
RESULTS AND DISCUSSION
Identification of Hepatic CAR Splice Variants (SVs)
To identify novel isoforms of rCAR, we amplified rCAR cDNA using primer pairs covering exon 1 through 9. PCR was performed with the total RNA extract of Wistar rat liver and the products were subcloned into the Zero Blunt TOPO Vector. Twenty-seven random clones were removed and sequenced. The distribution of the clones was as follows: sixteen clones coding for wild-type rCAR (CAR WT), two with a 3-bp deletion and 18-bp insertion (CAR SV1), four with an 18-bp insertion (CAR SV2), two with a 4-bp deletion (CAR SV3), one with an intron 7-insertion (CAR SV4), and one with an intron 8-insertion (CAR SV5) (Figs. 1A, B ). CAR SV4 and SV5 identical with those reported previously 9) were also detected in smal intestine (data not shown).
CAR WT is a protein of 358 amino acids (a.a.) with a the-oretical molecular weight of 39 kDa (Fig. 2) . The genomic structure of rCAR consists of nine exons and eight introns, with the translation start site in exon 2, and the stop codon in exon 9. CAR SV1 with 3 bp deleted from the 5Ј-end of exon 7 in frame and 18 bp inserted at the 5Ј-end of intron 8 with a premature termination codon, gives a 315 a.a. protein with a theoretical molecular weight of 34 kDa (Fig. 2) . CAR SV2, with 18 bp inserted at the 5Ј-end of intron 8 containing a novel termination codon, gives a 316 a.a. protein with a theoretical molecular weight of 34 kDa (Fig. 2) . CAR SV3, with 4 bp deleted from the 5Ј-end of exon 8, gives a truncated isoform of 298 a.a. with a theoretical molecular weight of 32 kDa (Fig. 2) . In CAR SV4, intron 7 (195 bp) was not completely spliced out, introducing a novel termination codon to give a protein of 307 a.a. with a theoretical molecular weight of 33 kDa (Fig. 2) . A complete intron 6 (91 bp) remained in CAR SV5, resulting in a 310 a.a. protein with a theoretical molecular weight of 34 kDa due to a novel stop codon in exon 8 (Fig. 2) . The amino acid sequences of CAR SVs are shown in Fig. 3 in comparison with the sequence of CAR WT. Western immunoblot analyses were conducted using the nuclear and cytoplasmic fractions of rat liver and lung samples to study whether CAR SVs would be expressed as pro-tein isoforms. The polyclonal antibodies recognizing the Nterminal regions shared by all the rCAR protein isoforms were employed. There can be seen two distinct immunoreactive bands in both subcellular fractions of liver homogenate but not in the lung counterparts (Fig. 3) . The upper band migrates to ca. 39 kDa, corresponding to the estimated size of the wild-type CAR, and the broad band in the range of 32 to 34 kDa could be attributed to CAR SVs. Comparing the band intensities of top (CAR WT) and bottom (CAR SVs), and the numbers of PCR-amplified cDNA colonies of CAR WT and SVs, CAR WT was expressed dominantly in liver in comparison with CAR SVs.
Transcription of Reporter Gene by CAR SVs and Their Effects on Transcription by CAR WT
To determine whether CAR SVs were transcriptionally active like CAR WT, a reporter gene assay was performed by transfecting a luciferase reporter construct carrying PBREM derived from the CYP2B1 gene promoter and individual CAR SVexpression plasmids. CAR WT has been shown to translocate to the nucleus and transactivate the PBREM-driven reporter genes in the absence of any ligands or activators in immortalized cell lines. 10, 11) CAR WT and SV4 activated PBREM-Luc transcription, while the other CAR SVs did not transactivate the reporter gene (Fig. 4 ). Next, we determined whether CAR SVs could affect transactivation caused by cotransfected CAR WT. As shown in Fig. 5 , none of the transactivation-inactive CAR SVs affected CAR WT (50 ng)-dependent transactivation at up to 150 ng. In contrast, CAR SV4 had a 2060 Vol. 28, No. 11 marginal but significant suppressive effect on the transactivation by CAR WT in a dose-dependent manner. We previously proposed two explanations concerning the correlation among CAR WT, SV4 and SV5. Both CAR SV4 and SV5 were detected in liver as well as CAR WT, whereas only CAR SV5 was detected in lung, where PB-dependent CYP2B induction was missing. 9) Therefore, CAR SV4 might be a hepatic intermediate of CAR WT, whereas CAR SV5 would be the terminal from in an alternative pathway. Alternatively, both CAR SV4 and SV5 are endoproducts not being processed into CAR WT. As the silent mutant of CAR SV4 lacking a splice donor in intron 7 (CAR SV4mu, Fig. 6A ) was found to be transactivationally inert (Fig. 6B) , the latter would not be the case. In fact, CAR SV4 should be further processed into CAR WT, which might be responsible for the transactivating potential of CAR SV4. The down-regulation of the transactivating activity of CAR WT by CAR SV4 (Fig. 5E ) could be attributed to the nature of CAR WT as can be seen in Fig.  5A , because of CAR SV4mut without splicing to CAR WT were devoid transactivating activity. However, the RT-PCR analysis showed that CAR WT was less abundant than the unspliced CAR SV4 in HepG2 cells transfected with the CAR SV4 expression plasmid (Fig. 6B) . Likewise, the CAR SV5 expression plasmid gave double bands corresponding to SV5 and the novel transcript by skipping intron 6 and exon 7, though this variant has never been detected in rat liver or lung. Taking all these findings into consideration, we propose that CAR SV4 and SV5 are not in the main pathway from the very precursor to mature CAR WT mRNA, though SV4 is partially processed to CAR WT by the splicing out of intron 7 (Fig. 7) .
Recently, alternative splicing was proposed a new factor restricting the expression of functional CARs at relevant sites. 12) As for human CAR, alternative splicing within exon 9 was proposedly involved in the control of the tissue-and differentiation state-specific expression of the functional form. The ubiquitous but weak expression of non-functional CAR isoforms appears to be associated with the alternative splicing within exon 9, ensuring that no functional transcripts are produced ectopically, and compensating for inappropriate transcription of the CAR promoter. In the case of rat CAR, CAR SV4 might be a candidate for a defective variant, which is ubiquitously expressed. Thus, alternative splicing contributes to the complex regulation of CAR expression and function.
In this study, we discovered novel rCAR splice variants, CAR SV1, SV2 and SV3, in liver in addition to the previously reported SV4 and SV5. In conclusion, SVs lacked both transactivation and dominant-negative potentials except for CAR SV4, in which the further splicing to CAR WT was expected. Tissue specific expression of CAR WT might be regulated by splicing events. The maturation of rCAR mRNA SV4 was confined into the CAR WT expressing tissues such as liver and small intestine, whereas lung the dead-ended route to SV5 was ubiquitously observed. 
